Axaron Bioscience AG Company Profile

04:11 EDT 18th March 2018 | BioPortfolio

Axaron Bioscience AG is a biotech company that aims to develop drugs which address the large-volume and fast growing neurodegenerative disorders market. The company has built an attractive portfolio of compounds focused on the treatment of stroke, Spinal Cord Injury (SCI), ALS (Amyotrophic Lateral Sclerosis) and Parkinson's disease. The most advanced drug candidate AX200 has already entered phase II stroke trials at the end of 2004. Another compound, AX201 is scheduled for phase II clinical trials for stroke in 2006. Based on its proprietary D FINE platform, Axaron is able to quickly identify and develop drugs with neuroprotective or neuroregenerative properties. This enables the company to generate a constant flow of new drug candidates.


Im Neuenheimer Feld 515


Phone: 49 (0) 6221 454 6
Fax: 49 (0) 6221 454 700

News Articles [269 Associated News Articles listed on BioPortfolio]

Crown Bioscience Inc.: Übertragbares FATZO Modell von CrownBio in präklinischen Forschungsprogrammen zu Diabetes Typ 2 von Eli Lilly verwendet

SANTA CLARA, Kalifornien (USA), 21. November 2017 (GLOBE NEWSWIRE) - Crown Bioscience (, eine hundertprozentige Tochtergesellschaft von Crown Bioscience International (TWS...

Crown Bioscience Inc.: CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs

SANTA CLARA, Calif., 2017-11-21 14:00 CET (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and devel...

Analyzing Harvard Bioscience

Harvard Bioscience and Illumina are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability...

Crown Bioscience announces availability of new translational models for obesity and diabetes in Europe

Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International and a global drug discovery and development services company providing translational platforms to advance oncology, inflam...

Lumen Bioscience raises $11.2M

Lumen Bioscience raised $11.2 million in venture funding to continue its research into making biologic medicines as well as c -More- 

Harvard Bioscience to Acquire DSI, Sells Denville Scientific

Management now expects a dramatic increase in Harvard Bioscience’s fiscal 2018 annual revenue

Nemus Bioscience Files Arbitration Petition Against Schneider Finance, LLC and SB Securities, ...

COSTA MESA, CA--(Marketwired - Nov 9, 2017) - NEMUS Bioscience, Inc.( OTCQB : NMUS) (the "Company") today announced that it has submitted a Read more...

Nemus Bioscience Announces $2,000,000 Series F Preferred Stock Financing

COSTA MESA, CA--(Marketwired - Nov 1, 2017) - NEMUS Bioscience, Inc. ( OTCQB : NMUS) today announced that it closed a Securities Purchase Read more...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

O24 [Revive Bioscience, Inc.]

Abraxane [Abraxis BioScience, LLC]

These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE ABRAXANE® for Injectable Suspension (paclitaxel protei...

Idkit hp one [Exalenz Bioscience Ltd.]

Package Insert IDkit:Hp™ for the Exalenz BreathID® System BREATH TEST FOR DETECTION of H. pylori

PubMed Articles [65 Associated PubMed Articles listed on BioPortfolio]

Nursing students collaborating to develop multiple-choice exam revision questions: A student engagement study.

Nursing students find bioscience subjects challenging. Bioscience exams pose particular concerns for these students, which may lead to students adopting a surface-approach to learning.

The nursification of a bioscience unit and its impact on student satisfaction and learning in an undergraduate nursing degree.

Undergraduate nursing students traditionally find bioscience difficult, which can be compounded by an inability to relate bioscience theory to nursing practice. Subsequently, many registered nurses fe...


Happy Birthday Karel!

From Polymers to Functional Biomaterials.

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Metabolic syndrome increases the risk for development of heart disease. Another condition associated with metabolic syndrome is fatty liver disease which is also referred to as nonalcoholi...

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

This pilot study will try to minimize the pain during exposure to a new red light source (RhodoLED®, Biofrontera Bioscience GmbH, Leverkusen, Germany) used for PDT without compromising it...

Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects

Photomodulation is a process which manipulates or regulates cell activity using light sources without thermal effect. Different studies have investigated the use of non-thermal low dose li...

Companies [307 Associated Companies listed on BioPortfolio]

Axaron Bioscience AG

Axaron Bioscience AG is a biotech company that aims to develop drugs which address the large-volume and fast growing neurodegenerative disorders market. The company has built an attractive portfolio o...

The Idaho Bioscience Association

The Idaho Bioscience Association is a non-profit organization that brings together corporate, academic and political leaders to educate the public and to promote bioscience activities in the state. B...

Sprint Bioscience

Sprint Bioscience AB (publ) is part of the new Swedish pharmaceutical industry. The company has the goal to develop drug candidates for the global pharmaceutical market within the...

Bioscience Bridge, LLC

Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we...

Target BioScience AG

Target BioScience AG is a consulting firm focused exclusively on the pharmaceutical and biotechnology fields. Our trademark is our highly practical approach. Target BioScience AG was originally founde...

More Information about "Axaron Bioscience AG" on BioPortfolio

We have published hundreds of Axaron Bioscience AG news stories on BioPortfolio along with dozens of Axaron Bioscience AG Clinical Trials and PubMed Articles about Axaron Bioscience AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Axaron Bioscience AG Companies in our database. You can also find out about relevant Axaron Bioscience AG Drugs and Medications on this site too.

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Corporate Database Quicklinks

Searches Linking to this Company Record